Is it time to implement prolonged infusions of beta-lactam antibiotics in and beyond critical care settings?
- PMID: 39600156
- DOI: 10.1111/imj.16584
Is it time to implement prolonged infusions of beta-lactam antibiotics in and beyond critical care settings?
References
-
- Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395: 200–211.
-
- Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019 – results from a systematic review and meta‐analysis. Crit Care 2020; 24: 239.
-
- Li L, Sunderland N, Rathnayake K, Westbrook JI. Epidemiology of Sepsis in Australian Public Hospitals. Sydney, New South Wales: Australian Commission on Safety and Quality in Health Care; 2020.
-
- The George Institute for Global Health. Cost of Sepsis in Australia. Sydney New South Wales: The George Institute for Global Health; 2021.
-
- Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1–10.
Publication types
LinkOut - more resources
Full Text Sources